SlideShare a Scribd company logo
1 of 24
Download to read offline
Discovering new drugs and
diagnostics from 300 billion
      points of data
            Atul Butte, MD, PhD
    Chief, Division of Systems Medicine,
         Department of Pediatrics,
  Center for Pediatric Bioinformatics, LPCH
             Stanford University

           abutte@stanford.edu
                @atulbutte
Disclosures
• Scientific founder and        • Honoraria
  advisory board membership         –   Lilly
    –   Genstruct                   –   Pfizer
    –   NuMedii                     –   Siemens
    –   Personalis                  –   Bristol Myers Squibb
    –   Carmenta                • Speakers’ bureau
• Past or present consultancy       – None
    –   Lilly
    –   Johnson and Johnson     • Companies started by students
    –   Roche                       –   Carmenta
    –   NuMedii                     –   NuMedii
    –   Genstruct                   –   Stimulomics
    –   Tercica                     –   NunaHealth
    –   Ansh Labs                   –   Praedicat
    –   Prevendia                   –   Flipora
# Downloadable Tumor
Available Cancer Types                         # Patients with Samples                          Updated
                                                                               Samples
Acute Myeloid Leukemia [LAML]                           202                      200            04/04/12
Bladder Urothelial Carcinoma [BLCA]                     89                        78            04/12/12
Brain Lower Grade Glioma [LGG]                          144                       80            04/10/12
Breast invasive carcinoma [BRCA]                        861                      866            04/08/12
Cervical squamous cell carcinoma and                    99                        37            04/12/12
endocervical adenocarcinoma [CESC]

Colon adenocarcinoma [COAD]                             423                      422            03/26/12

Glioblastoma multiforme [GBM]                           598                      581            04/09/12
Head and Neck squamous cell                             312                      292            04/13/12
carcinoma[HNSC]
Kidney renal clear cell carcinoma [KIRC]                502                      501            04/12/12

Kidney renal papillary cell carcinoma [KIRP]            103                      97             04/13/12

Liver hepatocellular carcinoma [LIHC]                   84                       55             03/24/12
Lung adenocarcinoma [LUAD]                              374                      351            04/12/12

Lung squamous cell carcinoma [LUSC]                     290                      283            04/13/12
Lymphoid Neoplasm Diffuse Large B-cell                  27                        0             04/12/12
Lymphoma [DLBC]
Lymphoid Neoplasm Non-Hodgkins                           2                        0             11/16/11
Lymphoma [LNNH]
Ovarian serous cystadenocarcinoma [OV]                  597                      591            04/13/12

Pancreatic adenocarcinoma [PAAD]                         48                      38             03/29/12

Prostate adenocarcinoma [PRAD]                          153                      153            04/13/12
Protein
Protein
Marina Sirota
                                          Joel Dudley




                        Lamb J, ..., Golub TR. Science, 2006.
Sirota M, Dudley JT, ..., Sweet-Cordero A, Sage J, Butte AJ.
                     Science Translational Medicine, 2011.
Anti-seizure drug works against a rat model of
inflammatory bowel disease




                                                                                           Marina Sirota
                                                                                             Joel Dudley
                                                                                        Mohan M Shenoy
Dudley JT, Sirota M, ..., Pasricha J, Butte AJ. Science Translational Medicine, 2011.       Jay Pasricha
Rat colonoscopy                                Rat with                               Inflammatory
                                               Inflammatory                              Bowel Disease
                                               Bowel Disease                                  After
                                                                                        Anti-seizure Drug

Dudley JT, Sirota M, ..., Pasricha J, Butte AJ. Science Translational Medicine, 2011.
Drug development

NuMedii lands 1st deal to spin drug data into product gold
San Francisco Business Times by Ron Leuty, Reporter
Date: Wednesday, October 3, 2012, 5:30am PDT - Last Modified: Wednesday, October 3, 2012, 6:27am PDT

           Ron Leuty
           Reporter- San Francisco Business
           Times
NuMedii Inc. is looking to make a big difference in drug
development with Big Data.

The Mountain View company co-founded by Stanford
University’s Atul Butte and his wife, former Affymetrix
executive Gini Deshpande, said Wednesday that it inked a
                                                                 Stanford University professor and NuMedii
deal to help drug developer Aptalis Pharma Inc. find new
                                                                 co-founder Atul Butte.
treatments for gastrointestinal disorders and cystic fibrosis.


                                                                                  Using data to find new drug-disease matches
                                                                                  wins startup NuMedii its first pharma deal
                                                                                  October 3, 2012 4:02 pm by Deanna Pogorelc | 1 Comments




                                                                                  Pairing existing drugs with new disease applications, using not wet labs but
                                                                                  computers, has landed a Stanford startup its first contract with a pharmaceutical
                                                                                  company.
Take Home Points
• Big Data is out there: molecular, clinical,
  individual, epidemiological.
  We can get to diagnostics and therapeutics.


• We can use big data to understand why diseases
  occur and what we can do about treating them.


• A new generation of investigators will imagine new
  questions and discoveries from these repositories
  of clinical and genomic measurements.
Collaborators
•   Takashi Kadowaki, Momoko Horikoshi, Kazuo Hara, Hiroshi Ohtsu / U Tokyo
•   Kyoko Toda, Satoru Yamada, Junichiro Irie / Kitasato Univ and Hospital
•   Shiro Maeda / RIKEN
•   Alejandro Sweet-Cordero, Julien Sage / Pediatric Oncology
•   Mark Davis, C. Garrison Fathman / Immunology
•   Russ Altman, Steve Quake / Bioengineering
•   Euan Ashley, Joseph Wu, Tom Quertermous / Cardiology
•   Mike Snyder, Carlos Bustamante, Anne Brunet / Genetics
•   Jay Pasricha / Gastroenterology
•   Rob Tibshirani, Brad Efron / Statistics
•   Hannah Valantine, Kiran Khush/ Cardiology
•   Ken Weinberg / Pediatric Stem Cell Therapeutics
•   Mark Musen, Nigam Shah / National Center for Biomedical Ontology
•   Minnie Sarwal / Nephrology
•   David Miklos / Oncology
Support
• Lucile Packard Foundation for Children's Health
• NIH: NIAID, NLM, NIGMS, NCI; NIDDK, NHGRI, NIA, NHLBI, NCATS
• March of Dimes
• Hewlett Packard
• Howard Hughes Medical Institute
• California Institute for Regenerative Medicine
• Scleroderma Research Foundation
• Clayville Research Fund
• PhRMA Foundation                               Admin and Tech Staff
• Stanford Cancer Center, Bio-X                  • Susan Aptekar
                                                 • Camilla Morrison
                                                 • Alex Skrenchuk
• Tarangini Deshpande
• Kimayani Deshpande

More Related Content

What's hot

Atul Butte's presentation to the Association of Medical School Pediatric Depa...
Atul Butte's presentation to the Association of Medical School Pediatric Depa...Atul Butte's presentation to the Association of Medical School Pediatric Depa...
Atul Butte's presentation to the Association of Medical School Pediatric Depa...University of California, San Francisco
 
UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...
UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...
UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...CTSI at UCSF
 
Presentation on Research Reproducibility at Friends of the National Library o...
Presentation on Research Reproducibility at Friends of the National Library o...Presentation on Research Reproducibility at Friends of the National Library o...
Presentation on Research Reproducibility at Friends of the National Library o...University of California, San Francisco
 
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...University of California, San Francisco
 
The Uneven Future of Evidence-Based Medicine
The Uneven Future of Evidence-Based MedicineThe Uneven Future of Evidence-Based Medicine
The Uneven Future of Evidence-Based MedicineIda Sim
 
Atul Butte's presentation at the From Data to Discovery symposium at Westat
Atul Butte's presentation at the From Data to Discovery symposium at WestatAtul Butte's presentation at the From Data to Discovery symposium at Westat
Atul Butte's presentation at the From Data to Discovery symposium at WestatUniversity of California, San Francisco
 
Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...
Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...
Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...University of California, San Francisco
 
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...The Hive
 
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit 2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit University of California, San Francisco
 
Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...
Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...
Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...University of California, San Francisco
 
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...Dexter Hadley
 

What's hot (20)

Precision Medicine World Conference 2017
Precision Medicine World Conference 2017Precision Medicine World Conference 2017
Precision Medicine World Conference 2017
 
Presentation given at UCSF Precision Medicine meeting 4/11/2015
Presentation given at UCSF Precision Medicine meeting 4/11/2015 Presentation given at UCSF Precision Medicine meeting 4/11/2015
Presentation given at UCSF Precision Medicine meeting 4/11/2015
 
Atul Butte's presentation at ASHG 2014
Atul Butte's presentation at ASHG 2014Atul Butte's presentation at ASHG 2014
Atul Butte's presentation at ASHG 2014
 
2014 farr institute presentation
2014 farr institute presentation2014 farr institute presentation
2014 farr institute presentation
 
Atul Butte's AAPS big data workshop presentation 6/2015
Atul Butte's AAPS big data workshop presentation 6/2015Atul Butte's AAPS big data workshop presentation 6/2015
Atul Butte's AAPS big data workshop presentation 6/2015
 
Atul Butte's presentation to the Association of Medical School Pediatric Depa...
Atul Butte's presentation to the Association of Medical School Pediatric Depa...Atul Butte's presentation to the Association of Medical School Pediatric Depa...
Atul Butte's presentation to the Association of Medical School Pediatric Depa...
 
UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...
UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...
UCSF Informatics Day 2014 - Neil Risch, "The Institute for Computational Heal...
 
2014 simr presentation
2014 simr presentation2014 simr presentation
2014 simr presentation
 
Presentation on Research Reproducibility at Friends of the National Library o...
Presentation on Research Reproducibility at Friends of the National Library o...Presentation on Research Reproducibility at Friends of the National Library o...
Presentation on Research Reproducibility at Friends of the National Library o...
 
2014 07 ismb personalized medicine
2014 07 ismb personalized medicine2014 07 ismb personalized medicine
2014 07 ismb personalized medicine
 
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
 
The Uneven Future of Evidence-Based Medicine
The Uneven Future of Evidence-Based MedicineThe Uneven Future of Evidence-Based Medicine
The Uneven Future of Evidence-Based Medicine
 
Intro: California Initiative to Advance Precision Medicine Workshop
Intro: California Initiative to Advance Precision Medicine WorkshopIntro: California Initiative to Advance Precision Medicine Workshop
Intro: California Initiative to Advance Precision Medicine Workshop
 
Atul Butte's presentation at the From Data to Discovery symposium at Westat
Atul Butte's presentation at the From Data to Discovery symposium at WestatAtul Butte's presentation at the From Data to Discovery symposium at Westat
Atul Butte's presentation at the From Data to Discovery symposium at Westat
 
Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...
Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...
Atul Butte's presentation at #AMIA2021 for the Knowledge Discovery and Data M...
 
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
 
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit 2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
 
Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...
Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...
Presentation for the CSIR Fourth Paradigm Institute Silver Jubilee (Bangalore...
 
CTNeT Overview ASCO 2012
CTNeT Overview ASCO 2012CTNeT Overview ASCO 2012
CTNeT Overview ASCO 2012
 
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
 

Viewers also liked

Personalized Medicine World Conference 2011 Medivo
Personalized Medicine World Conference 2011 MedivoPersonalized Medicine World Conference 2011 Medivo
Personalized Medicine World Conference 2011 MedivoSundeep Bhan
 
Venture Scanner Health Technology 2016 Q4
Venture Scanner Health Technology 2016 Q4Venture Scanner Health Technology 2016 Q4
Venture Scanner Health Technology 2016 Q4Nathan Pacer
 
presentation of brands
presentation of brandspresentation of brands
presentation of brandsSilence Speed
 
Sample Marketing Presentation/Plan
Sample Marketing Presentation/PlanSample Marketing Presentation/Plan
Sample Marketing Presentation/PlanJay DeLane
 
20 Tweetable Quotes to Inspire Marketing & Design Creative Genius
20 Tweetable Quotes to Inspire Marketing & Design Creative Genius20 Tweetable Quotes to Inspire Marketing & Design Creative Genius
20 Tweetable Quotes to Inspire Marketing & Design Creative GeniusIMPACT Branding & Design LLC
 
brand positioning with examples
brand positioning with examplesbrand positioning with examples
brand positioning with examplesLinel Dias
 
40 Tools in 20 Minutes: Hacking your Marketing Career
40 Tools in 20 Minutes: Hacking your Marketing Career40 Tools in 20 Minutes: Hacking your Marketing Career
40 Tools in 20 Minutes: Hacking your Marketing CareerEric Leist
 
What REALLY Differentiates The Best Content Marketers From The Rest
What REALLY Differentiates The Best Content Marketers From The RestWhat REALLY Differentiates The Best Content Marketers From The Rest
What REALLY Differentiates The Best Content Marketers From The RestRoss Simmonds
 
Digital transformation in 50 soundbites
Digital transformation in 50 soundbitesDigital transformation in 50 soundbites
Digital transformation in 50 soundbitesJulie Dodd
 
Eco-nomics, The hidden costs of consumption
Eco-nomics, The hidden costs of consumptionEco-nomics, The hidden costs of consumption
Eco-nomics, The hidden costs of consumptionJosh Beatty
 
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfsHow to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfsMarketingProfs
 
Creating Powerful Customer Experiences
Creating Powerful Customer ExperiencesCreating Powerful Customer Experiences
Creating Powerful Customer ExperiencesDigital Surgeons
 
All About Beer
All About Beer All About Beer
All About Beer Ethos3
 
6 Snapchat Hacks Too Easy To Ignore
6 Snapchat Hacks Too Easy To Ignore6 Snapchat Hacks Too Easy To Ignore
6 Snapchat Hacks Too Easy To IgnoreGary Vaynerchuk
 
Five Killer Ways to Design The Same Slide
Five Killer Ways to Design The Same SlideFive Killer Ways to Design The Same Slide
Five Killer Ways to Design The Same SlideCrispy Presentations
 

Viewers also liked (20)

Personalized Medicine World Conference 2011 Medivo
Personalized Medicine World Conference 2011 MedivoPersonalized Medicine World Conference 2011 Medivo
Personalized Medicine World Conference 2011 Medivo
 
Venture Scanner Health Technology 2016 Q4
Venture Scanner Health Technology 2016 Q4Venture Scanner Health Technology 2016 Q4
Venture Scanner Health Technology 2016 Q4
 
presentation of brands
presentation of brandspresentation of brands
presentation of brands
 
Sample Marketing Presentation/Plan
Sample Marketing Presentation/PlanSample Marketing Presentation/Plan
Sample Marketing Presentation/Plan
 
20 Tweetable Quotes to Inspire Marketing & Design Creative Genius
20 Tweetable Quotes to Inspire Marketing & Design Creative Genius20 Tweetable Quotes to Inspire Marketing & Design Creative Genius
20 Tweetable Quotes to Inspire Marketing & Design Creative Genius
 
2015 Travel Trends
2015 Travel Trends 2015 Travel Trends
2015 Travel Trends
 
brand positioning with examples
brand positioning with examplesbrand positioning with examples
brand positioning with examples
 
40 Tools in 20 Minutes: Hacking your Marketing Career
40 Tools in 20 Minutes: Hacking your Marketing Career40 Tools in 20 Minutes: Hacking your Marketing Career
40 Tools in 20 Minutes: Hacking your Marketing Career
 
What REALLY Differentiates The Best Content Marketers From The Rest
What REALLY Differentiates The Best Content Marketers From The RestWhat REALLY Differentiates The Best Content Marketers From The Rest
What REALLY Differentiates The Best Content Marketers From The Rest
 
Digital transformation in 50 soundbites
Digital transformation in 50 soundbitesDigital transformation in 50 soundbites
Digital transformation in 50 soundbites
 
Eco-nomics, The hidden costs of consumption
Eco-nomics, The hidden costs of consumptionEco-nomics, The hidden costs of consumption
Eco-nomics, The hidden costs of consumption
 
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfsHow to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
 
Creating Powerful Customer Experiences
Creating Powerful Customer ExperiencesCreating Powerful Customer Experiences
Creating Powerful Customer Experiences
 
All About Beer
All About Beer All About Beer
All About Beer
 
6 Snapchat Hacks Too Easy To Ignore
6 Snapchat Hacks Too Easy To Ignore6 Snapchat Hacks Too Easy To Ignore
6 Snapchat Hacks Too Easy To Ignore
 
Build a Better Entrepreneur Pitch Deck
Build a Better Entrepreneur Pitch DeckBuild a Better Entrepreneur Pitch Deck
Build a Better Entrepreneur Pitch Deck
 
You Suck At PowerPoint! by @jessedee
You Suck At PowerPoint! by @jessedeeYou Suck At PowerPoint! by @jessedee
You Suck At PowerPoint! by @jessedee
 
The Minimum Loveable Product
The Minimum Loveable ProductThe Minimum Loveable Product
The Minimum Loveable Product
 
Five Killer Ways to Design The Same Slide
Five Killer Ways to Design The Same SlideFive Killer Ways to Design The Same Slide
Five Killer Ways to Design The Same Slide
 
Displaying Data
Displaying DataDisplaying Data
Displaying Data
 

Similar to 2013 01 pmwc atul butte scrubbed

Acs finding promiscuous old drugs for new uses-final
Acs   finding promiscuous old drugs for new uses-finalAcs   finding promiscuous old drugs for new uses-final
Acs finding promiscuous old drugs for new uses-finalSean Ekins
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Pete Shuster
 
Kim Solez Bridge between transplantation and regenerative medicine vancouver3
Kim Solez Bridge between transplantation and regenerative medicine vancouver3Kim Solez Bridge between transplantation and regenerative medicine vancouver3
Kim Solez Bridge between transplantation and regenerative medicine vancouver3Kim Solez ,
 
Kim Solez Transition transplant path to tissue engineering path new banff
Kim Solez Transition transplant path to tissue engineering path new banffKim Solez Transition transplant path to tissue engineering path new banff
Kim Solez Transition transplant path to tissue engineering path new banffKim Solez ,
 
Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1
Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1
Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1Sumith Kularatne
 
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...Kim Solez ,
 
Indications discovery and drug repurposing
Indications discovery and drug repurposingIndications discovery and drug repurposing
Indications discovery and drug repurposingSean Ekins
 
MQ_medical sciences posterv8-3
MQ_medical sciences posterv8-3MQ_medical sciences posterv8-3
MQ_medical sciences posterv8-3Yagiz Alp Aksoy
 
Transition transplant path to tissue engineer path new banff class 2017
Transition transplant path to tissue engineer path new banff class 2017 Transition transplant path to tissue engineer path new banff class 2017
Transition transplant path to tissue engineer path new banff class 2017 Kim Solez ,
 
Disrupting drug discovery one disease at a time
Disrupting drug discovery one disease at a timeDisrupting drug discovery one disease at a time
Disrupting drug discovery one disease at a timeSean Ekins
 
CMMRF Catch the Vision
CMMRF Catch the VisionCMMRF Catch the Vision
CMMRF Catch the Visionflgyr
 
Genetic and Engineering news Webinar slides
Genetic and Engineering news Webinar slidesGenetic and Engineering news Webinar slides
Genetic and Engineering news Webinar slidesSean Ekins
 
EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum
 

Similar to 2013 01 pmwc atul butte scrubbed (20)

Acs finding promiscuous old drugs for new uses-final
Acs   finding promiscuous old drugs for new uses-finalAcs   finding promiscuous old drugs for new uses-final
Acs finding promiscuous old drugs for new uses-final
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13
 
Kim Solez Bridge between transplantation and regenerative medicine vancouver3
Kim Solez Bridge between transplantation and regenerative medicine vancouver3Kim Solez Bridge between transplantation and regenerative medicine vancouver3
Kim Solez Bridge between transplantation and regenerative medicine vancouver3
 
Kim Solez Transition transplant path to tissue engineering path new banff
Kim Solez Transition transplant path to tissue engineering path new banffKim Solez Transition transplant path to tissue engineering path new banff
Kim Solez Transition transplant path to tissue engineering path new banff
 
Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1
Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1
Sumith_Kularatne_Intl_Innovation_Cancer_Research_Media_LR-1
 
Beth baber oen science summit
Beth baber oen science summitBeth baber oen science summit
Beth baber oen science summit
 
TJU_Newsletter 2008_summer Li photo
TJU_Newsletter 2008_summer Li photoTJU_Newsletter 2008_summer Li photo
TJU_Newsletter 2008_summer Li photo
 
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...
 
Indications discovery and drug repurposing
Indications discovery and drug repurposingIndications discovery and drug repurposing
Indications discovery and drug repurposing
 
Campbell stewardship report 2011
Campbell stewardship report 2011Campbell stewardship report 2011
Campbell stewardship report 2011
 
MQ_medical sciences posterv8-3
MQ_medical sciences posterv8-3MQ_medical sciences posterv8-3
MQ_medical sciences posterv8-3
 
Transition transplant path to tissue engineer path new banff class 2017
Transition transplant path to tissue engineer path new banff class 2017 Transition transplant path to tissue engineer path new banff class 2017
Transition transplant path to tissue engineer path new banff class 2017
 
Disrupting drug discovery one disease at a time
Disrupting drug discovery one disease at a timeDisrupting drug discovery one disease at a time
Disrupting drug discovery one disease at a time
 
Folding
FoldingFolding
Folding
 
CMMRF Catch the Vision
CMMRF Catch the VisionCMMRF Catch the Vision
CMMRF Catch the Vision
 
Catch The Vision
Catch The VisionCatch The Vision
Catch The Vision
 
Folding
FoldingFolding
Folding
 
Getman Apr29 F I N A L
Getman  Apr29  F I N A LGetman  Apr29  F I N A L
Getman Apr29 F I N A L
 
Genetic and Engineering news Webinar slides
Genetic and Engineering news Webinar slidesGenetic and Engineering news Webinar slides
Genetic and Engineering news Webinar slides
 
EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_Manolio
 

More from University of California, San Francisco

More from University of California, San Francisco (8)

Presentation at ISMB NIH Office of Data Science Strategy Panel
Presentation at ISMB NIH Office of Data Science Strategy PanelPresentation at ISMB NIH Office of Data Science Strategy Panel
Presentation at ISMB NIH Office of Data Science Strategy Panel
 
Atul Butte's presentation at CTIC 2020
Atul Butte's presentation at CTIC 2020Atul Butte's presentation at CTIC 2020
Atul Butte's presentation at CTIC 2020
 
Thinking about Twitter for Academics
Thinking about Twitter for AcademicsThinking about Twitter for Academics
Thinking about Twitter for Academics
 
Presentation by Atul Butte at the NSTC Interagency Working Group on Biologica...
Presentation by Atul Butte at the NSTC Interagency Working Group on Biologica...Presentation by Atul Butte at the NSTC Interagency Working Group on Biologica...
Presentation by Atul Butte at the NSTC Interagency Working Group on Biologica...
 
Atul Butte presentation on 2019-02-05 for Accelerating biology 2019: Towards ...
Atul Butte presentation on 2019-02-05 for Accelerating biology 2019: Towards ...Atul Butte presentation on 2019-02-05 for Accelerating biology 2019: Towards ...
Atul Butte presentation on 2019-02-05 for Accelerating biology 2019: Towards ...
 
Atul Butte NIPS 2017 ML4H
Atul Butte NIPS 2017 ML4HAtul Butte NIPS 2017 ML4H
Atul Butte NIPS 2017 ML4H
 
Atul Butte's presentation for the FDA 5th Annual Scientific Computing Days
Atul Butte's presentation for the FDA 5th Annual Scientific Computing DaysAtul Butte's presentation for the FDA 5th Annual Scientific Computing Days
Atul Butte's presentation for the FDA 5th Annual Scientific Computing Days
 
Atul Butte presentation at the Morris Collen 100 birthday celebration
Atul Butte presentation at the Morris Collen 100 birthday celebrationAtul Butte presentation at the Morris Collen 100 birthday celebration
Atul Butte presentation at the Morris Collen 100 birthday celebration
 

2013 01 pmwc atul butte scrubbed

  • 1. Discovering new drugs and diagnostics from 300 billion points of data Atul Butte, MD, PhD Chief, Division of Systems Medicine, Department of Pediatrics, Center for Pediatric Bioinformatics, LPCH Stanford University abutte@stanford.edu @atulbutte
  • 2. Disclosures • Scientific founder and • Honoraria advisory board membership – Lilly – Genstruct – Pfizer – NuMedii – Siemens – Personalis – Bristol Myers Squibb – Carmenta • Speakers’ bureau • Past or present consultancy – None – Lilly – Johnson and Johnson • Companies started by students – Roche – Carmenta – NuMedii – NuMedii – Genstruct – Stimulomics – Tercica – NunaHealth – Ansh Labs – Praedicat – Prevendia – Flipora
  • 3.
  • 4.
  • 5.
  • 6. # Downloadable Tumor Available Cancer Types # Patients with Samples Updated Samples Acute Myeloid Leukemia [LAML] 202 200 04/04/12 Bladder Urothelial Carcinoma [BLCA] 89 78 04/12/12 Brain Lower Grade Glioma [LGG] 144 80 04/10/12 Breast invasive carcinoma [BRCA] 861 866 04/08/12 Cervical squamous cell carcinoma and 99 37 04/12/12 endocervical adenocarcinoma [CESC] Colon adenocarcinoma [COAD] 423 422 03/26/12 Glioblastoma multiforme [GBM] 598 581 04/09/12 Head and Neck squamous cell 312 292 04/13/12 carcinoma[HNSC] Kidney renal clear cell carcinoma [KIRC] 502 501 04/12/12 Kidney renal papillary cell carcinoma [KIRP] 103 97 04/13/12 Liver hepatocellular carcinoma [LIHC] 84 55 03/24/12 Lung adenocarcinoma [LUAD] 374 351 04/12/12 Lung squamous cell carcinoma [LUSC] 290 283 04/13/12 Lymphoid Neoplasm Diffuse Large B-cell 27 0 04/12/12 Lymphoma [DLBC] Lymphoid Neoplasm Non-Hodgkins 2 0 11/16/11 Lymphoma [LNNH] Ovarian serous cystadenocarcinoma [OV] 597 591 04/13/12 Pancreatic adenocarcinoma [PAAD] 48 38 03/29/12 Prostate adenocarcinoma [PRAD] 153 153 04/13/12
  • 7.
  • 8.
  • 11.
  • 12.
  • 13. Marina Sirota Joel Dudley Lamb J, ..., Golub TR. Science, 2006. Sirota M, Dudley JT, ..., Sweet-Cordero A, Sage J, Butte AJ. Science Translational Medicine, 2011.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Anti-seizure drug works against a rat model of inflammatory bowel disease Marina Sirota Joel Dudley Mohan M Shenoy Dudley JT, Sirota M, ..., Pasricha J, Butte AJ. Science Translational Medicine, 2011. Jay Pasricha
  • 20. Rat colonoscopy Rat with Inflammatory Inflammatory Bowel Disease Bowel Disease After Anti-seizure Drug Dudley JT, Sirota M, ..., Pasricha J, Butte AJ. Science Translational Medicine, 2011.
  • 21. Drug development NuMedii lands 1st deal to spin drug data into product gold San Francisco Business Times by Ron Leuty, Reporter Date: Wednesday, October 3, 2012, 5:30am PDT - Last Modified: Wednesday, October 3, 2012, 6:27am PDT Ron Leuty Reporter- San Francisco Business Times NuMedii Inc. is looking to make a big difference in drug development with Big Data. The Mountain View company co-founded by Stanford University’s Atul Butte and his wife, former Affymetrix executive Gini Deshpande, said Wednesday that it inked a Stanford University professor and NuMedii deal to help drug developer Aptalis Pharma Inc. find new co-founder Atul Butte. treatments for gastrointestinal disorders and cystic fibrosis. Using data to find new drug-disease matches wins startup NuMedii its first pharma deal October 3, 2012 4:02 pm by Deanna Pogorelc | 1 Comments Pairing existing drugs with new disease applications, using not wet labs but computers, has landed a Stanford startup its first contract with a pharmaceutical company.
  • 22. Take Home Points • Big Data is out there: molecular, clinical, individual, epidemiological. We can get to diagnostics and therapeutics. • We can use big data to understand why diseases occur and what we can do about treating them. • A new generation of investigators will imagine new questions and discoveries from these repositories of clinical and genomic measurements.
  • 23. Collaborators • Takashi Kadowaki, Momoko Horikoshi, Kazuo Hara, Hiroshi Ohtsu / U Tokyo • Kyoko Toda, Satoru Yamada, Junichiro Irie / Kitasato Univ and Hospital • Shiro Maeda / RIKEN • Alejandro Sweet-Cordero, Julien Sage / Pediatric Oncology • Mark Davis, C. Garrison Fathman / Immunology • Russ Altman, Steve Quake / Bioengineering • Euan Ashley, Joseph Wu, Tom Quertermous / Cardiology • Mike Snyder, Carlos Bustamante, Anne Brunet / Genetics • Jay Pasricha / Gastroenterology • Rob Tibshirani, Brad Efron / Statistics • Hannah Valantine, Kiran Khush/ Cardiology • Ken Weinberg / Pediatric Stem Cell Therapeutics • Mark Musen, Nigam Shah / National Center for Biomedical Ontology • Minnie Sarwal / Nephrology • David Miklos / Oncology
  • 24. Support • Lucile Packard Foundation for Children's Health • NIH: NIAID, NLM, NIGMS, NCI; NIDDK, NHGRI, NIA, NHLBI, NCATS • March of Dimes • Hewlett Packard • Howard Hughes Medical Institute • California Institute for Regenerative Medicine • Scleroderma Research Foundation • Clayville Research Fund • PhRMA Foundation Admin and Tech Staff • Stanford Cancer Center, Bio-X • Susan Aptekar • Camilla Morrison • Alex Skrenchuk • Tarangini Deshpande • Kimayani Deshpande